Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anett B. Hegewald"'
Publikováno v:
FASEB BioAdvances, Vol 1, Iss 8, Pp 481-492 (2019)
Abstract Extracellular microRNAs (miRs) have been proposed as important blood‐based biomarkers for several diseases. Contrary to proteins and other RNA classes, miRs are stable and easily detectable in body fluids. In this respect, miRs represent a
Externí odkaz:
https://doaj.org/article/835f74f53a2b4b67bc1f656440519760
Autor:
Anett B. Hegewald, Kai Breitwieser, Sarah M. Ottinger, Fariborz Mobarrez, Marina Korotkova, Bence Rethi, Per-Johan Jakobsson, Anca I. Catrina, Heidi Wähämaa, Meike J. Saul
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and joint destruction. Cell-derived small extracellular vesicles (sEV) mediate cell-to-cell communication in the synovial microenvironment by carrying mi
Externí odkaz:
https://doaj.org/article/92aa2dca3c05457893e321bf6cff55cc
Autor:
Meike J. Saul, Anett B. Hegewald, Anne C. Emmerich, Elena Ossipova, Marc Vogel, Isabell Baumann, Kim Kultima, Johan Lengqivst, Dieter Steinhilber, Per Johan Jakobsson
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
MicroRNAs (miRs) are small noncoding RNAs which control the expression of target genes by either translational repression or RNA degradation, known as canonical miR functions. The recent discovery that miR-328 has a noncanonical function and can acti
Externí odkaz:
https://doaj.org/article/ca392a7a976341a5af1ec22be8f630ef
Publikováno v:
FASEB bioAdvances
FASEB BioAdvances, Vol 1, Iss 8, Pp 481-492 (2019)
FASEB BioAdvances, Vol 1, Iss 8, Pp 481-492 (2019)
Extracellular microRNAs (miRs) have been proposed as important blood‐based biomarkers for several diseases. Contrary to proteins and other RNA classes, miRs are stable and easily detectable in body fluids. In this respect, miRs represent a perfect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::567acfd567705f6950d812e5f68d4111
http://europepmc.org/articles/PMC6996320
http://europepmc.org/articles/PMC6996320
Autor:
Anett B. Hegewald, Dieter Steinhilber, Meike J. Saul, Beatrix Suess, Rolf Marschalek, Michaela Müller-McNicoll, Florian Groher
Publikováno v:
Prostaglandinsother lipid mediators. 133
5-Lipoxygenase (5-LO) catalyzes the initial two steps of the conversion of arachidonic acid to leukotrienes which represent a group of pro-inflammatory lipid mediators involved in immune defense reactions as well as inflammation, allergy and cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4aaedc5c2a0a2d09a1ca760a7c34561
https://pubmed.ncbi.nlm.nih.gov/28803964
https://pubmed.ncbi.nlm.nih.gov/28803964